Literature DB >> 4008651

Human alveolar macrophages synthesize factor VII in vitro. Possible role in interstitial lung disease.

H A Chapman, C L Allen, O L Stone, D S Fair.   

Abstract

Both fibrin and tissue macrophages are prominent in the histopathology of chronic inflammatory pulmonary disease. We therefore examined the procoagulant activity of freshly lavaged human alveolar macrophages in vitro. Intact macrophages (5 X 10(5) cells) from 13 healthy volunteers promoted clotting of whole plasma in a mean of 65 s. Macrophage procoagulant activity was at least partially independent of exogenous Factor VII as judged by a mean clotting time of 99 s in Factor VII-deficient plasma and by neutralization of procoagulant activity by an antibody to Factor VII. Immunoprecipitation of extracts of macrophages metabolically labeled with [35S]methionine by Factor VII antibody and analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis revealed a labeled protein consistent in size with the known molecular weight of blood Factor VII, 48,000. The addition of 50 micrograms of unlabeled, purified Factor VII blocked recovery of the 48,000-mol wt protein. In addition, supernatants of cultured macrophages from six normal volunteers had Factor X-activating activity that was suppressed an average of 71% after culture in the presence of 50 microM coumadin or entirely by the Factor VII antibody indicating that Factor VII synthesized by the cell was biologically active. Endotoxin in vitro induced increases in cellular tissue factor but had no consistent effect on macrophage Factor VII activity. We also examined the tissue factor and Factor VII activities of freshly lavaged alveolar cells from nine subjects with clinical and/or histologic evidence of sarcoidosis. Four of the nine subjects expressed increased tissue factor and seven of nine had increased Factor VII activity over the normal range (P less than 0.01). We estimate the mean Factor VII associated with the cells of sarcoid patients to be 4.7 ng/10(6) cells (range 0.4-20) as compared to a mean of 0.74 ng/10(6) cells (range 0.2-2) for that of normal subjects. Along with previous data showing synthesis of plasminogen activator, these findings indicate that human alveolar macrophages normally synthesize and express measurable amounts of the initial enzymes of proteolytic reactions regulating both fibrin deposition and fibrin resorption. Abnormalities in Factor VII activity in a small group of patients with sarcoidosis raise the possibility that modulation of fibrin turnover by macrophages may contribute to the pathology of this and perhaps other interstitial lung diseases.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4008651      PMCID: PMC425564          DOI: 10.1172/JCI111922

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  37 in total

1.  Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation.

Authors:  B Osterud; S I Rapaport
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

Review 2.  Blood coagulation and fibrinolysis in tissue culture and tissue repair.

Authors:  T Astrup
Journal:  Biochem Pharmacol       Date:  1968-03       Impact factor: 5.858

3.  Clinical interpretation of bilateral hilar adenopathy.

Authors:  R H Winterbauer; N Belic; K D Moores
Journal:  Ann Intern Med       Date:  1973-01       Impact factor: 25.391

4.  Gram-negative sepsis: detection of endotoxemia with the limulus test. With studies of associated changes in blood coagulation, serum lipids, and complement.

Authors:  J Levin; T E Poore; N S Young; S Margolis; N P Zauber; A S Townes; W R Bell
Journal:  Ann Intern Med       Date:  1972-01       Impact factor: 25.391

5.  A distinct "slow" cellular pathway involving soluble mediators for the T cell-instructed induction of monocyte tissue factor activity in an allogeneic immune response.

Authors:  H Helin; T S Edgington
Journal:  J Immunol       Date:  1984-05       Impact factor: 5.422

6.  Mechanism of activation of bovine factor VII. Products of cleavage by factor Xa.

Authors:  R Radcliffe; Y Nemerson
Journal:  J Biol Chem       Date:  1976-08-25       Impact factor: 5.157

7.  Tissue factor generation by human mononuclear cells: effects of endotoxin and dissociation of tissue factor generation from mitogenic response.

Authors:  F R Rickles; J Levin; J A Hardin; C F Barr; M E Conrad
Journal:  J Lab Clin Med       Date:  1977-04

8.  Delayed-type hypersensitivity skin reactions in congenital afibrinogenemia lack fibrin deposition and induration.

Authors:  R B Colvin; M W Mosesson; H F Dvorak
Journal:  J Clin Invest       Date:  1979-06       Impact factor: 14.808

9.  Coagulant activity of leukocytes. Tissue factor activity.

Authors:  J Niemetz
Journal:  J Clin Invest       Date:  1972-02       Impact factor: 14.808

10.  Role of the clotting system in cell-mediated hypersensitivity. I. Fibrin deposition in delayed skin reactions in man.

Authors:  R B Colvin; R A Johnson; M C Mihm; H F Dvorak
Journal:  J Exp Med       Date:  1973-09-01       Impact factor: 14.307

View more
  25 in total

1.  Intra-alveolar fibrosis of idiopathic bronchiolitis obliterans-organizing pneumonia. Cell-matrix patterns.

Authors:  S Peyrol; J F Cordier; J A Grimaud
Journal:  Am J Pathol       Date:  1990-07       Impact factor: 4.307

2.  Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome.

Authors:  S Idell; K K James; E G Levin; B S Schwartz; N Manchanda; R J Maunder; T R Martin; J McLarty; D S Fair
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

3.  Identification of vitamin K-dependent carboxylase activity in lung type II cells but not in lung macrophages.

Authors:  R Wallin; S R Rannels
Journal:  Biochem J       Date:  1988-03-01       Impact factor: 3.857

4.  Proceedings of the British Thoracic Society, Scottish Thoracic Society and Thoracic Society of Australia. The 1987 summer meeting. 1-3 July, Edinburgh. Abstracts.

Authors: 
Journal:  Thorax       Date:  1987-09       Impact factor: 9.139

Review 5.  Secretory products of macrophages.

Authors:  C F Nathan
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

Review 6.  Breast cancer phenotypes regulated by tissue factor-factor VII pathway: Possible therapeutic targets.

Authors:  Shiro Koizume; Yohei Miyagi
Journal:  World J Clin Oncol       Date:  2014-12-10

7.  Early coagulation events induce acute lung injury in a rat model of blunt traumatic brain injury.

Authors:  Hideki Yasui; Deborah L Donahue; Mark Walsh; Francis J Castellino; Victoria A Ploplis
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-05-17       Impact factor: 5.464

8.  A severe deficiency of coagulation factor VIIa results in attenuation of the asthmatic response in mice.

Authors:  Kazuhiko Shinagawa; Victoria A Ploplis; Francis J Castellino
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-03-13       Impact factor: 5.464

9.  H7N9 and other pathogenic avian influenza viruses elicit a three-pronged transcriptomic signature that is reminiscent of 1918 influenza virus and is associated with lethal outcome in mice.

Authors:  Juliet Morrison; Laurence Josset; Nicolas Tchitchek; Jean Chang; Jessica A Belser; David E Swayne; Mary J Pantin-Jackwood; Terrence M Tumpey; Michael G Katze
Journal:  J Virol       Date:  2014-07-02       Impact factor: 5.103

10.  Atherothrombosis and Thromboembolism: Position Paper from the Second Maastricht Consensus Conference on Thrombosis.

Authors:  H M H Spronk; T Padro; J E Siland; J H Prochaska; J Winters; A C van der Wal; J J Posthuma; G Lowe; E d'Alessandro; P Wenzel; D M Coenen; P H Reitsma; W Ruf; R H van Gorp; R R Koenen; T Vajen; N A Alshaikh; A S Wolberg; F L Macrae; N Asquith; J Heemskerk; A Heinzmann; M Moorlag; N Mackman; P van der Meijden; J C M Meijers; M Heestermans; T Renné; S Dólleman; W Chayouâ; R A S Ariëns; C C Baaten; M Nagy; A Kuliopulos; J J Posma; P Harrison; M J Vries; H J G M Crijns; E A M P Dudink; H R Buller; Y M C Henskens; A Själander; S Zwaveling; O Erküner; J W Eikelboom; A Gulpen; F E C M Peeters; J Douxfils; R H Olie; T Baglin; A Leader; U Schotten; B Scaf; H M M van Beusekom; L O Mosnier; L van der Vorm; P Declerck; M Visser; D W J Dippel; V J Strijbis; K Pertiwi; A J Ten Cate-Hoek; H Ten Cate
Journal:  Thromb Haemost       Date:  2018-01-29       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.